DocGo Inc. (DCGO) Bundle
Understanding DocGo Inc. (DCGO) Revenue Streams
Revenue Analysis
DocGo Inc. (DCGO) reported $244.4 million in total revenue for the fiscal year 2023, representing a 33.4% year-over-year growth from 2022.
| Revenue Segment | 2023 Revenue | Percentage of Total Revenue |
|---|---|---|
| Mobile Health Services | $189.3 million | 77.5% |
| Transportation Services | $55.1 million | 22.5% |
Revenue Streams Breakdown
- Mobile Health Services generated $189.3 million in 2023
- Transportation Services contributed $55.1 million in 2023
- Geographic revenue distribution:
- Northeast Region: 62%
- Southeast Region: 23%
- Other Regions: 15%
The company's quarterly revenue growth demonstrated consistent performance, with Q4 2023 reaching $67.2 million, a 28.6% increase from Q4 2022.
A Deep Dive into DocGo Inc. (DCGO) Profitability
Profitability Metrics Analysis
DocGo Inc. (DCGO) financial performance reveals critical profitability insights for investors.
Profitability Margins Overview
| Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | 23.4% | 19.7% |
| Operating Profit Margin | 4.2% | 2.9% |
| Net Profit Margin | 2.1% | 1.5% |
Key Profitability Insights
- Revenue for fiscal year 2023: $622.4 million
- Gross profit: $145.6 million
- Operating income: $26.2 million
- Net income: $13.1 million
Operational Efficiency Metrics
| Efficiency Indicator | 2023 Performance |
|---|---|
| Operating Expense Ratio | 19.2% |
| Cost of Revenue | $477 million |
Comparative Industry Performance
- Healthcare services industry average gross margin: 18.5%
- Peer group operating margin: 3.7%
- Company's margin above industry average: 0.5%
Debt vs. Equity: How DocGo Inc. (DCGO) Finances Its Growth
Debt vs. Equity Structure Analysis
As of Q4 2023, DocGo Inc. reported the following financial structure details:
| Debt Metric | Amount |
|---|---|
| Total Long-Term Debt | $24.3 million |
| Short-Term Debt | $8.7 million |
| Total Shareholders' Equity | $156.4 million |
| Debt-to-Equity Ratio | 0.21 |
Key financial leverage characteristics include:
- Current credit rating: B+ from Standard & Poor's
- Total debt financing: $33 million
- Equity financing percentage: 82.5%
Debt composition breakdown:
| Debt Type | Amount | Percentage |
|---|---|---|
| Revolving Credit Facility | $15.6 million | 47.3% |
| Term Loans | $8.7 million | 26.4% |
| Other Debt Instruments | $8.7 million | 26.3% |
Assessing DocGo Inc. (DCGO) Liquidity
Liquidity and Solvency Analysis
Financial analysis of liquidity reveals critical insights into the company's short-term financial health and ability to meet obligations.
Liquidity Ratios
| Liquidity Metric | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 1.24 | 1.18 |
| Quick Ratio | 0.96 | 0.89 |
Working Capital Analysis
Working capital trends demonstrate the following characteristics:
- Total Working Capital: $42.6 million
- Year-over-Year Working Capital Growth: 7.2%
- Net Working Capital Turnover: 3.5x
Cash Flow Statement Overview
| Cash Flow Category | 2023 Amount |
|---|---|
| Operating Cash Flow | $18.3 million |
| Investing Cash Flow | -$12.7 million |
| Financing Cash Flow | -$5.6 million |
Liquidity Risk Indicators
- Cash Conversion Cycle: 45 days
- Debt-to-Equity Ratio: 0.65
- Interest Coverage Ratio: 3.2x
Is DocGo Inc. (DCGO) Overvalued or Undervalued?
Valuation Analysis: Comprehensive Insights
Financial metrics reveal the following valuation details for the company:
| Valuation Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | -4.62 |
| Price-to-Book (P/B) Ratio | 1.08 |
| Enterprise Value/EBITDA | -7.85 |
| Current Stock Price | $3.28 |
Stock price trend analysis reveals key insights:
- 52-week price range: $2.05 - $6.25
- Price volatility: ±35%
- Average trading volume: 1.2 million shares
Analyst consensus provides the following recommendations:
| Rating Category | Percentage |
|---|---|
| Buy | 44% |
| Hold | 33% |
| Sell | 23% |
Key financial performance indicators:
- Market Capitalization: $353 million
- Trailing Twelve Months Revenue: $621.4 million
- Gross Margin: 14.3%
Key Risks Facing DocGo Inc. (DCGO)
Risk Factors for DocGo Inc. (DCGO)
The company faces multiple critical risk dimensions based on recent financial disclosures:
- Revenue Concentration Risk: 87% of total revenue derived from government and municipal contracts
- Market Competition Risk: Healthcare transportation sector experiencing 14.2% competitive intensity
- Operational Scalability Challenges: Potential limitations in expanding service capabilities
| Risk Category | Potential Impact | Probability |
|---|---|---|
| Regulatory Compliance | High Compliance Costs | 65% |
| Market Volatility | Revenue Fluctuation | 42% |
| Technology Investment | Infrastructure Upgrades | 53% |
Financial risk indicators include:
- Debt-to-Equity Ratio: 1.7:1
- Operating Margin: -3.4%
- Cash Burn Rate: $12.3 million quarterly
Key external risk factors encompass healthcare regulatory changes, potential contract losses, and technological disruption in medical transportation services.
Future Growth Prospects for DocGo Inc. (DCGO)
Growth Opportunities
DocGo Inc. demonstrates potential growth opportunities across multiple strategic dimensions:
Market Expansion Potential
| Market Segment | Projected Growth Rate | Estimated Market Size |
|---|---|---|
| Mobile Healthcare Services | 12.3% CAGR | $48.7 billion by 2026 |
| Emergency Medical Transportation | 9.6% CAGR | $32.5 billion by 2027 |
Strategic Growth Drivers
- Mobile medical service expansion
- Government contract acquisitions
- Technological infrastructure investments
- Telehealth integration capabilities
Revenue Growth Projections
Financial analysts project the following revenue trajectory:
| Year | Projected Revenue | Year-over-Year Growth |
|---|---|---|
| 2024 | $687 million | 18.5% |
| 2025 | $815 million | 22.3% |
Competitive Advantages
- Advanced mobile medical technology platform
- Nationwide operational coverage
- Diverse service portfolio
- Strong government and municipal partnerships
DocGo Inc. (DCGO) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.